665 related articles for article (PubMed ID: 28947034)
21. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
[TBL] [Abstract][Full Text] [Related]
22. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
23. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.
Vande Weygaerde Y; Cardinaels N; Bomans P; Chin T; Boelens J; André E; Van Braeckel E; Lorent N
BMC Infect Dis; 2019 Dec; 19(1):1061. PubMed ID: 31847834
[TBL] [Abstract][Full Text] [Related]
25. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472
[TBL] [Abstract][Full Text] [Related]
26. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of clinical manifestations between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus pulmonary diseases].
Duan HF; Wang J; Chu NH; Huang XR; Wang QF; Huang HR; Liang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Aug; 35(8):588-91. PubMed ID: 23158006
[TBL] [Abstract][Full Text] [Related]
28. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline].
Wagner D; Lange C
Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
30. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.
Carrillo MC; Patsios D; Wagnetz U; Jamieson F; Marras TK
Can Assoc Radiol J; 2014 Aug; 65(3):207-13. PubMed ID: 24325924
[TBL] [Abstract][Full Text] [Related]
32. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
33. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of infections due to Mycobacterium avium complex.
Kasperbauer SH; Daley CL
Semin Respir Crit Care Med; 2008 Oct; 29(5):569-76. PubMed ID: 18810690
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
Zo S; Kim H; Kwon OJ; Jhun BW
Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Disease Caused by Non-Tuberculous Mycobacteria.
Wassilew N; Hoffmann H; Andrejak C; Lange C
Respiration; 2016; 91(5):386-402. PubMed ID: 27207809
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
Clin Infect Dis; 2023 Feb; 76(3):e1408-e1415. PubMed ID: 35607719
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use.
Kim SM; Chong YP; Lee HJ; Shim TS; Jo KW
Microbiol Spectr; 2023 Jun; 11(3):e0474122. PubMed ID: 37022189
[TBL] [Abstract][Full Text] [Related]
40. Spatial Heterogeneity of Nontuberculous Mycobacterial Pulmonary Disease in Shanghai: Insights from a Ten-Year Population-Based Study.
Zhang Y; Sun R; Yu C; Li J; Lin H; Huang J; Wang Y; Shen X; Jiang Y; Yang C; Xu B
Int J Infect Dis; 2024 Jun; 143():107001. PubMed ID: 38461931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
